BioProduction Congress 2018
October 9 - 10, 2018 - Convention Centre Dublin, Spencer Dock, N Wall Quay North Dock, Dublin 1, Dublin IEKNect365 Life Science
LS.Registrations@Knect365.com
Phone:+44 (0) 20 3377 3279
Bringing together over 400 of the most influential biomanufacturing folks, BioProduction 2018 will provide you with the latest updates across all phases of biomanufacturing, practical tips for tackling regulatory challenges head on, and a detailed overview of industry innovations in mammalian and microbial production. Get insights on the latest technologies, upstream/downstream processing, process analytics, the implementation of continuous manufacturing, facility design, flexibility facilities and single use systems to reduce inefficiencies during the biomanufacturing process. WHAT MAKES THIS CONGRESS DIFFERENT? CO-LOCATION WITH BIOANALYTICAL and FORMULATION SUMMIT Immerse yourself in analytical method development for higher order structures, CQA's, post transitional modifications, aggregation, formulation and stability testing INNOVATIVE SOLUTIONS. Bioproduction helps you overcome the major challenges faced in the manufacturing of biological therapies: primarily monoclonal antibodies (mAbs). Also this year get to grips with the production of novel non monoclonal antibody products, e.g. biosimilars, bispecific, antibody drug conjugates and fragments and gain an understanding of how microbial expression systems can help drive these products to market. Find out more about the event highlights here COMPREHENSIVE AGENDA. It looks at the latest strategies to optimise upstream and downstream processing, minimise costs and stress on internal resources, as well as the strategies used to ensure product quality, safety and yield in line with international regulations. COMMERCIAL MANUFACTURING APPROACH. BioProduction looks at all aspects of large scale, commercial/ GMP manufacturing including the latest technologies, facility design, single use systems, continuous manufacturing and strategies for reducing inefficiencies during the bio manufacturing process, rather than just looking at ways to optimise the process